Speakers

Jeremy Parker is the Head of Early Chemical Development, a World-Class CMC department with responsibility for early phase Drug Substance.

The department’s responsibilities span from early engagement with Discovery Chemistry groups to manufacture of Phase II Clinical material, and its key skill areas include Analytical Chemistry, Crystallisation, Isotope Chemistry, Large-Scale Laboratory (Kilo-Lab) Manufacturing, Process Chemistry, Process Design, Process Engineering, Route Design and Separation Science.

Jeremy is a member of the Pharmaceutical Sciences Leadership Team, and also the Global Chemistry Leadership Team within AstraZeneca.

External to AstraZeneca, Jeremy is a member of the Editorial Advisory Board of Organic Process Research and Development, Chairman of the Centre for Biocatalytic Manufacture of New Modalities Prosperity Partnership at the University of Manchester, and a Trustee of the Society of Chemical Industry.

Presentation Title: Trends Shaping Early Chemical Development & How Outsourcing Partnerships Can Adapt to Meet the Challenges

Abstract: Trends Shaping Early Chemical Development & How Outsourcing Partnerships can Adapt to Meet the Challenges

A discussion covering some key challenges facing Early CMC Drug Substance departments:
- Speed, Quality & Cost
- Molecular Complexity
- New Modalities
- Impurities
- Shipping
- Sustainability
- Climate Change
- High Throughput Experimentation
- New Technologies
- Data and Digitalisation